Evaluation of various inverse docking schemes in multiple targets identification

Journal of Molecular Graphics and Modelling

Volumn 29, Issue 3, 2010, Pages 326-330

  Hui fang, Liu ^a   Qing, Shen ^a   Jian, Zhang ^b   Wei, Fu ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

FlexX; GOLD; Inverse docking; TarFisDock; Target database; Target identification; TarSearch M; TarSearch X

Indexed keywords

FLEXX; INVERSE DOCKING; TARFISDOCK; TARGET DATABASE; TARGET IDENTIFICATION; TARSEARCH-M; TARSEARCH-X;

DATABASE SYSTEMS; GOLD; LAKES; STATISTICAL TESTS;

DOCKING;

ARTICLE; DATA BASE; DRUG TARGETING; EVALUATION; MOLECULAR DOCKING; PRIORITY JOURNAL; TOXICITY; VALIDATION STUDY;

BINDING SITES; COMPUTER SIMULATION; DATABASES, PROTEIN; DRUG DESIGN; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 78649525086     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmgm.2010.09.004     Document Type: Article

References (32)

1. Ezerzer C., Dolgin M., Skovorodnikova J., Harris N. Chemokine receptor-derived peptides as multi-target drug leads for the treatment of inflammatory diseases. Peptides 2009, 30:1296-1305.
2. Cavalli A., Bolognesi M.L., Minarini A., Rosini M., Tumiatti V., Recanatini M., Melchiorre C. Multi-target-directed ligands to combat neurodegenerative diseases. J. Med. Chem. 2008, 51:347-372.
3. Xie L., Li J., Bourne P.E. Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors. PloS Comput. Biol. 2009, 5:1-10.
4. Paolini G.V., Shapland R.H.B., van Hoorn W.P., Mason J.S., Hopkins A.L. Global mapping of pharmacological space. Nat. Biotechnol. 2006, 24:805-815.
5. Morphy R., Rankovic Z. Designed multiple ligands. An emerging drug discovery paradigm. J. Med. Chem. 2005, 48:6523-6543.
6. Kennedy T. Managing the drug discovery/development interface. Drug Discov. Today 1997, 2:436-444.
7. Howbrook D.N., van der Valk A.M., O'Shaughnessy M.C., Sarker D.K., Baker S.C., Lloyd A.W. Developments in microarray technologies. Drug Discov. Today 2003, 8:642-651.
8. Scherer L., Rossi J. Approaches for the sequencespecific knockdown of mRNA. Nat. Biotechnol. 2003, 21:1457-1465.
9. Tan S.Y., Guschin D., Davalos A., Lee Y.L., Snowden A.W., Jouvenot Y., Zhang H.S., Howes K., McNamara A.R., Lai A., Ullman C., Reynolds L., Moore M., Isalan M., Berg L.P., Campos B., Qi H., Spratt S.K., Case C.C., Pabo C.O., Campisi J., Gregory P.D. Zinc-finger protein-targeted gene regulation: genomewide single-gene specificity. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:11997-12002.
10. Khersonsky S.M., Jung D.W., Kang T.W., Walsh D.P., Moon H.S., Jo H., Jacobson E.M., Shetty V., Neubert T.A., Chang Y.T. Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. J. Am. Chem. Soc. 2003, 125:11804-11805.
11. Chen G.Y.J., Uttamchandani M., Zhu Q., Wang G., Yao S.Q. Developing a strategy for activity-based detection of enzymes in a protein microarray. ChemBioChem 2003, 4:336-339.
12. Suzuki C., Daigo Y., Kikuchi T., Katagiri T., Nakamura Y. Identification of COX17 as a therapeutic target for non-small cell lung cancer. Cancer Res. 2003, 63:7038-7041.
13. Lum P.Y., Armour C.D., Stepaniants S.B., Cavet G., Wolf M.K., Butler J.S., Hinsha J.C., Garnier P., Prestwich G.D., Leonardson A., Garrett-Engele P., Rush C.M., Bard M., Schimmack G., Phillips J.W., Roberts C.J., Shoemaker D.D. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 2004, 116:121-137.
14. Cai J.H., Han C., Hu T.C., Zhang J., Wu D.L., Wang F.D., Liu Y.Q., Ding J.P., Chen K.X., Yue J.M., Shen X., Jiang H.L. Peptide deformylase is a potential target for anti-Helicobacter pylori drugs: Reverse docking, enzymatic assay, and X-ray crystallography validation. Protein Sci. 2006, 15:2071-2081.
15. Bernard P, Dufresne-Favetta C., Favetta P., Do Q.T., Himbert F., Zubrzycki S., Scior T., Lugnier C. Application of drug repositioning strategy to TOFISOPAM. Curr. Med. Chem. 2008, 15:3196-3203.
16. Chen Y.Z., Ung C.Y. Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach. J. Mol. Graph. Model. 2001, 20:199-218.
17. Wang R.X., Lu Y.P., Fang X.L., Wang S.M. An extensive test of 14 scoring functions using the PDBbind refined set of 800 protein-ligand complexes. J. Chem. Inf. Comput. Sci. 2004, 44:2114-2125.
18. Kulharia M., Goody R.S., Jackson R.N. Information theory-based scoring function for the structure-based prediction of protein-ligand binding affinity. J. Chem. Inf. Model. 2008, 48:1990-1998.
19. The DrugBank, http://www.drugbank.ca/.
20. The Protein Data Bank, http://www.rcsb.org/pdb/home/home.do.
21. The Computed Atlas of Surface Topography server, http://sts-fw.bioengr.uic.edu/castp/index.php.
22. Joe D., Zheng O., Jeffery T., Andrew B., Yaron T., Jie L. CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated resiudes. Nucleic Acids Res. 2006, 34:W116-W118.
23. Sadowski J., Gasteiger J., Klebe G. Comparison of automatic 3-dimensional model builders using 639 X-ray structures. J. Chem. Inf. Comput. Sci. 1994, 34:1000-1008.
24. Wang R.X., Lai L.H., Wang S.M. Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J. Comput. Aided Mol. Des. 2002, 16:11-26.
25. Yang C.Y., Wang R.X., Wang S.M. M-score: a knowledge-based potential scoring function accounting for protein atom mobility. J. Med. Chem. 2006, 49:5903-5911.
26. The Target Fishing Dock public server, http://www.dddc.ac.cn/tarfisdock/index.php.
27. Claussen H., Gastreich M., Apelt V., Greene J., Hindle S.A., Lemmen C. The FlexX database docking environment - rational extraction of receptor based pharmacophores. Curr. Drug Discov. Technol. 2004, 1:49-60.
28. Verdonk M.L., Cole J.C., Hartshorn M.J., Murray C.W., Taylor R.D. Improved protein-ligand docking using GOLD. Protein Struct. Funct. Genet. 2003, 52:609-623.
29. Matthias R., Bernd K., Thomas L., Gerhard K. A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol. 1996, 261:470-489.
30. Sato H., Shewchuk L.M., Tang J. Prediction of multiple binding modes of the CDK2 inhibitors, anilinopyrazoles, using the automated docking programs GOLD, FlexX, and LigandFit: an evaluation of performance. J. Chem. Inf. Model. 2006, 46:2552-2562.
31. The Potential Drug Target Database, http://www.dddc.ac.cn/pdtd/index.php.
32. Gao Z.T., Li H.L., Zhang H.L., Liu X.F., Kang L., Luo X.M., Zhu W.L., Chen K.K., Wang X.C., Jiang H.L. PDTD: a web-accessible protein database for drug target identification. BMC Bioinf. 2008, 9:104-110.